Pfizer Ltd

Pfizer Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Pfizer Ltd

₹ 4,249 -0.63%
25 Apr - close price
pfizerindia.com BSE: 500680 NSE: PFIZER
About

Pfizer Ltd is engaged in manufacturing, marketing, trading and export of pharmaceutical products. It manufactures products through its own facility and also has various independent contract/ third party manufacturers based across the country and sells its products through independent distributors primarily in India.[1]
It is the 3rd largest multinational pharmaceutical company in India.[2]

Key Points

Parentage
The company is a subsidiary of Pfizer Inc. one of the world’s leading biopharma companies with a presence in over 125 countries. Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. [1] [2]

Website BSE NSE
  • Market Cap ₹ 19,438 Cr.
  • Current Price ₹ 4,249
  • High / Low ₹ 6,453 / 3,701
  • Stock P/E 31.6
  • Book Value ₹ 820
  • Dividend Yield 0.82 %
  • ROCE 22.0 %
  • ROE 16.1 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 35.5%

Cons

  • The company has delivered a poor sales growth of 1.05% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Multinational

Part of BSE Allcap BSE 250 SmallCap Index BSE 400 MidSmallCap Index Nifty MidSmallcap 400 Nifty Smallcap 250

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024
676 550 593 637 622 573 531 575 540 547 563 589 538
481 384 401 406 418 391 421 393 387 357 385 399 392
Operating Profit 195 165 192 232 203 182 111 183 153 189 177 189 146
OPM % 29% 30% 32% 36% 33% 32% 21% 32% 28% 35% 32% 32% 27%
18 17 -118 213 27 12 33 36 44 75 42 43 43
Interest 2 4 4 3 4 3 3 3 3 7 2 2 2
Depreciation 27 34 27 26 26 26 16 15 18 14 15 15 15
Profit before tax 184 145 43 415 201 165 126 201 176 244 203 215 172
Tax % 22% 13% 25% 25% 25% 21% 26% 26% 26% 27% 26% 26% 26%
144 126 33 311 151 130 94 149 130 179 151 158 128
EPS in Rs 31.46 27.50 7.12 68.00 32.93 28.34 20.44 32.56 28.41 39.10 32.94 34.61 27.89
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
1,049 1,112 1,853 2,012 1,966 1,969 2,082 2,152 2,239 2,611 2,425 2,193 2,236
865 872 1,438 1,579 1,616 1,468 1,516 1,578 1,526 1,775 1,616 1,555 1,534
Operating Profit 184 239 414 433 350 501 566 574 712 836 809 638 702
OPM % 18% 22% 22% 22% 18% 25% 27% 27% 32% 32% 33% 29% 31%
519 109 44 97 232 114 167 183 81 63 134 185 203
Interest 2 1 2 1 2 1 2 11 15 11 13 15 13
Depreciation 8 8 250 58 63 66 71 103 109 115 106 62 58
Profit before tax 694 340 207 470 517 548 660 642 669 773 824 746 834
Tax % 27% 35% 66% 35% 35% 34% 35% 21% 26% 21% 24% 26%
503 221 70 305 337 360 429 509 498 613 624 551 616
EPS in Rs 168.62 74.01 15.26 66.67 73.62 78.71 93.79 111.29 108.77 133.90 136.38 120.52 134.54
Dividend Payout % 19% 486% 82% 22% 27% 25% 24% 297% 32% 26% 51% 29%
Compounded Sales Growth
10 Years: 7%
5 Years: 1%
3 Years: -1%
TTM: 1%
Compounded Profit Growth
10 Years: 10%
5 Years: 5%
3 Years: 3%
TTM: 21%
Stock Price CAGR
10 Years: 8%
5 Years: -3%
3 Years: 0%
1 Year: 1%
Return on Equity
10 Years: 16%
5 Years: 18%
3 Years: 19%
Last Year: 16%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 30 30 46 46 46 46 46 46 46 46 46 46 46
Reserves 1,665 629 1,927 2,118 2,373 2,637 2,966 3,350 2,347 2,819 3,162 3,550 3,705
0 0 2 2 2 2 2 2 63 39 41 40 37
365 318 638 722 840 1,004 926 1,007 810 997 752 593 671
Total Liabilities 2,060 977 2,614 2,888 3,261 3,690 3,940 4,405 3,266 3,901 4,001 4,229 4,459
26 20 944 925 902 950 886 973 894 869 749 713 689
CWIP 0 3 13 3 15 1 0 1 3 1 8 0 3
Investments 46 44 43 37 0 0 0 0 0 0 0 0 0
1,988 909 1,614 1,923 2,343 2,739 3,054 3,432 2,369 3,030 3,244 3,516 3,767
Total Assets 2,060 977 2,614 2,888 3,261 3,690 3,940 4,405 3,266 3,901 4,001 4,229 4,459

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
-16 132 113 345 329 332 98 323 427 667 356 257
626 103 68 -701 -250 -238 35 1,530 -469 -575 -36 54
-43 -1,360 -1 -62 -83 -110 -110 -164 -1,571 -181 -346 -235
Net Cash Flow 567 -1,125 181 -417 -3 -17 23 1,690 -1,613 -88 -26 75

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 49 57 32 26 20 29 30 29 18 20 23 31
Inventory Days 181 148 191 167 148 147 189 198 199 173 175 200
Days Payable 165 156 165 157 178 245 213 197 130 102 91 77
Cash Conversion Cycle 65 49 58 36 -10 -69 6 31 87 91 107 154
Working Capital Days 7 25 7 -9 -46 -57 -15 -7 13 -8 3 31
ROCE % 19% 29% 24% 22% 17% 21% 23% 20% 23% 29% 26% 22%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
63.92% 63.92% 63.92% 63.92% 63.92% 63.92% 63.92% 63.92% 63.92% 63.92% 63.92% 63.92%
2.55% 2.55% 2.77% 2.80% 2.81% 2.82% 3.03% 3.32% 3.22% 3.54% 2.74% 2.18%
14.83% 14.88% 14.93% 14.89% 14.89% 15.00% 15.15% 15.32% 15.83% 16.03% 16.80% 17.10%
18.70% 18.65% 18.39% 18.38% 18.37% 18.24% 17.87% 17.42% 17.00% 16.50% 16.54% 16.79%
No. of Shareholders 1,23,4491,22,0281,17,9501,17,1941,15,9881,16,9481,12,4561,09,2141,06,09898,8241,05,0151,08,261

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Concalls